Craig A. Wheeler - 17 Apr 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Craig Wheeler
Issuer symbol
APLS
Transactions as of
17 Apr 2025
Net transactions value
+$513,149
Form type
4
Filing time
21 Apr 2025, 16:23:01 UTC
Previous filing
07 Jun 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +16,483 $0.000000 16,483 17 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Award $513,149 +28,195 $18.20 28,195 17 Apr 2025 Common Stock 28,195 $18.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit was granted on April 17, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as adirector at his election.
F2 This represents a stock option award granted April 17, 2025 that vest 1/3rd per year over a three-year period subject to continued service.